Soothing Singapore and Malaysian citizens… ‘We will start vaccination after safety verification’
On the 13th (local time), the first day of vaccination for a novel coronavirus infection (Corona 19), a nurse is getting a Pfizer vaccine in Ciudad Juarez, a Mexican border city. /yunhap newsIt has been found that not a few countries are experiencing internal pain after rushing to purchase a vaccine made in China to overcome the novel coronavirus infection (Corona 19).
The New York Times (NYT) reported on the 26th (local time) that delivery delays and opaque data for the Chinese-made Corona 19 vaccine were a problem in some countries. In particular, reports that Chinese-made vaccines are less effective than Pfizer-Bioentech or Moder or vaccines are heating up the dissatisfied public opinion.
In the case of the Philippines, some lawmakers have criticized the government’s decision to purchase a vaccine from China’s Sinovac. Singapore and Malaysia, which also bought synovac vaccines, are soothing anxious citizens with the intention of “after confirming that the Chinese vaccine is safe and effective, we will begin vaccination.”
Former Singaporean Foreign Minister Villahari Kaushikan said, “There is insufficient data on the vaccine,” and “I will not buy any Chinese vaccines now.” The immune effect of Chinese vaccines was initially known to be over 90%, but in Indonesia it was only 68%.
In addition, a recent study showed that the immune effect of Chinese vaccines was only over 50%.
In Turkey and Brazil, delays in vaccine delivery by Chinese pharmaceutical companies were a problem. Turkey promised the public that 10 million doses of sinovac vaccine would be supplied by December last year, but only 3 million doses were secured by the beginning of this month. China recently cited increasing concerns about the re-proliferation of Corona 19 in some regions as reasons for delayed delivery.
Brazil recently imported 2 million doses of AstraZeneca vaccine produced in India amid delays in delivery of vaccine ingredients to China. Earlier, China’s Sinoparm and Sinobac were confident that they could produce 2 billion doses of vaccine within this year. They have completed contracts with more than 24 countries, mainly in the Middle East, Africa and Asia, with low prices.
NYT said that the Chinese government tried to increase its influence in the international community with the corona 19 vaccine ahead, but the delay in delivery was counterproductive due to controversy over the efficacy of the drug. However, despite this controversy, it is pointed out that countries that have not purchased Pfizer, Moder, or vaccines will have no choice but to rely on Chinese vaccines because there is no alternative. A health expert in Turkey said, “There is no other vaccine other than made in China,” and “I will wait for my vaccination sequence.”
/ Intern reporter Jisu Kang [email protected]